Update in the management of gastroenteropancreatic neuroendocrine tumors Review


Authors: Sedlack, A. J. H.; Varghese, D. G.; Naimian, A.; Yazdian Anari, P.; Bodei, L.; Hallet, J.; Riechelmann, R. P.; Halfdanarson, T.; Capdevilla, J.; Del Rivero, J.
Review Title: Update in the management of gastroenteropancreatic neuroendocrine tumors
Abstract: Neuroendocrine neoplasms are a diverse group of neoplasms that can occur in various areas throughout the body. Well-differentiated neuroendocrine tumors (NETs) most often arise in the gastrointestinal tract, termed gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Although GEP-NETs are still uncommon, their incidence and prevalence have been steadily increasing over the past decades. The primary treatment for GEP-NETs is surgery, which offers the best chance for a cure. However, because GEP-NETs are often slow-growing and do not cause symptoms until they have spread widely, curative surgery is not always an option. Significant advances have been made in systemic and locoregional treatment options in recent years, including peptide-receptor radionuclide therapy with α and β emitters, somatostatin analogs, chemotherapy, and targeted molecular therapies. © 2024 American Cancer Society.
Keywords: adult; clinical article; review; pancreatic neoplasms; radiotherapy; prevalence; pathology; neuroendocrine tumor; gastrointestinal neoplasms; pancreas tumor; delayed diagnosis; drug therapy; intestine tumor; intestinal neoplasms; stomach neoplasms; therapy; stomach tumor; somatostatin; neuroendocrine tumors; neuroendocrine carcinoma; molecularly targeted therapy; gastrointestinal tumor; molecular targeted therapy; gastroenteropancreatic neuroendocrine tumor; procedures; humans; human; peptide receptor radionuclide therapy; gastro-enteropancreatic neuroendocrine tumor
Journal Title: Cancer
Volume: 130
Issue: 18
ISSN: 0008-543X
Publisher: Wiley Blackwell  
Date Published: 2024-09-15
Start Page: 3090
End Page: 3105
Language: English
DOI: 10.1002/cncr.35463
PUBMED: 39012928
PROVIDER: scopus
DOI/URL:
Notes: Review -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lisa   Bodei
    205 Bodei